OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
ARUY56

Arunjyoti Bio Ventures Ltd

Non-Paper Containers & PackagingVerified

Arunjyoti Bio Ventures has a debt-to-equity ratio of 0.81, indicating a moderate level of leverage, and a current ratio of 2.8, suggesting it has sufficient short-term assets to cover its liabilities. However, the company's free cash flow is negative at -46.48 million, and capital expenditures are -58.72 million, indicating significant investment in long-term assets. The company's liquidity is assessed as medium, with a key flag noting that net cash is negative after subtracting total debt. In terms of profitability, the company's return on equity is -5.63%, and return on assets is -3.06%, both of which are negative and below the typical performance metrics for the Non-Paper Containers & Packaging industry. The operating income is 22.48 million, but the net income is negative at -18.22 million, indicating that the company is not currently generating a profit after all expenses. The company's revenue is concentrated in co-packing services for a multinational corporation, with no disclosed geographic diversification. The financial data does not provide segment-specific revenue details, but the business model is heavily dependent on a single major client. This concentration could pose a risk if the client reduces its orders or shifts its business elsewhere. Looking at the growth trajectory, the company's revenue is 281.65 million, but there is no provided outlook for the current or next fiscal year. The negative net income and high capital expenditures suggest that the company is investing in its operations, which could be a sign of future growth. However, the lack of positive net income indicates that the company is not currently profitable. The risk assessment highlights a medium liquidity risk and a low dilution risk. The company's negative net cash position after subtracting total debt is a key liquidity concern. The dilution risk is low, and there are no adjustments applied to the valuation metrics, suggesting that the company's capital structure is stable. There are no recent events or filings mentioned in the provided data that would indicate significant changes in the company's operations or financial status. The company's business model and financial performance are based on the latest available financial data, and there are no disclosed events that would suggest a material change in the near future.

30-day price · ARUY-0.90 (-13.0%)
Low$5.64High$10.99Close$6.01As of15 May, 00:00 UTC
Profile
CompanyArunjyoti Bio Ventures Ltd
TickerARUY.BO
SectorBasic Materials
BusinessApplied Resources
Industry groupApplied Resources
IndustryNon-Paper Containers & Packaging
AI analysis

Business. Arunjyoti Bio Ventures Limited provides co-packing services for beverages, including non-carbonated drinks and juices, for a multinational corporation, and also offers retail services.

Classification. Arunjyoti Bio Ventures is classified under the Basic Materials economic sector, Applied Resources business sector, and Non-Paper Containers & Packaging industry, with a confidence level of 0.92.

Arunjyoti Bio Ventures has a debt-to-equity ratio of 0.81, indicating a moderate level of leverage, and a current ratio of 2.8, suggesting it has sufficient short-term assets to cover its liabilities. However, the company's free cash flow is negative at -46.48 million, and capital expenditures are -58.72 million, indicating significant investment in long-term assets. The company's liquidity is assessed as medium, with a key flag noting that net cash is negative after subtracting total debt. In terms of profitability, the company's return on equity is -5.63%, and return on assets is -3.06%, both of which are negative and below the typical performance metrics for the Non-Paper Containers & Packaging industry. The operating income is 22.48 million, but the net income is negative at -18.22 million, indicating that the company is not currently generating a profit after all expenses. The company's revenue is concentrated in co-packing services for a multinational corporation, with no disclosed geographic diversification. The financial data does not provide segment-specific revenue details, but the business model is heavily dependent on a single major client. This concentration could pose a risk if the client reduces its orders or shifts its business elsewhere. Looking at the growth trajectory, the company's revenue is 281.65 million, but there is no provided outlook for the current or next fiscal year. The negative net income and high capital expenditures suggest that the company is investing in its operations, which could be a sign of future growth. However, the lack of positive net income indicates that the company is not currently profitable. The risk assessment highlights a medium liquidity risk and a low dilution risk. The company's negative net cash position after subtracting total debt is a key liquidity concern. The dilution risk is low, and there are no adjustments applied to the valuation metrics, suggesting that the company's capital structure is stable. There are no recent events or filings mentioned in the provided data that would indicate significant changes in the company's operations or financial status. The company's business model and financial performance are based on the latest available financial data, and there are no disclosed events that would suggest a material change in the near future.
Key takeaways
  • Arunjyoti Bio Ventures has a moderate level of leverage with a debt-to-equity ratio of 0.81.
  • The company's return on equity and return on assets are both negative, indicating poor profitability.
  • The company's revenue is heavily concentrated in co-packing services for a single multinational corporation.
  • The company is investing in long-term assets, as indicated by the high capital expenditures.
  • The company's liquidity is assessed as medium, with a key flag noting a negative net cash position after subtracting total debt.
  • The dilution risk is low, and there are no adjustments applied to the valuation metrics.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyUnknown error in universe processing
Revenue$281.7M
Gross profit$229.4M
Operating income$22.5M
Net income-$18.2M
R&D
SG&A
D&A
SBC
Operating cash flow$14.5M
CapEx-$58.7M
Free cash flow-$46.5M
Total assets$596.2M
Total liabilities$272.4M
Total equity$323.8M
Cash & equivalents$5.9M
Long-term debt$262.1M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$323.8M
Net cash-$256.2M
Current ratio2.8
Debt/Equity0.8
ROA-3.1%
ROE-5.6%
Cash conversion-80.0%
CapEx/Revenue-20.8%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Non-Paper Containers & Packaging · cohort 3 companies
MetricARUYActivity
Op margin8.0%12.9% medp25 12.7% · p75 13.1%bottom quartile
Net margin-6.5%3.6% medp25 0.2% · p75 6.8%bottom quartile
Gross margin81.4%20.0% medp25 14.1% · p75 29.1%top quartile
R&D / revenue1.5% medp25 0.9% · p75 2.2%
CapEx / revenue-20.8%3.3% medp25 2.6% · p75 5.2%bottom quartile
Debt / equity81.0%143.2% medp25 92.9% · p75 161.6%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-03 23:27 UTC#a5968207
Source: analysis-pipeline (hybrid)Generated: 2026-05-03 23:28 UTCJob: 24bca6dc